Health ❯ Healthcare

Prescription Drugs

Drug Pricing Cost Management Medicare Drug Affordability Drug Costs Cost Reduction Drug Coverage Discount Programs Opioids Cost of Medications

4 ARTICLES

last mo.

Administration Ends Temporary Medicare Part D Insurer Subsidy for 2027

CMS says the move is meant to limit federal spending and restore competition while final consumer impacts will depend on 2027 plan bids published in September.

5 ARTICLES

3mo ago

CMS Projects U.S. Health Spending Will Reach Nearly $9 Trillion by 2034

46 ARTICLES

4mo ago

White House Adds More Than 600 Generics to TrumpRx and Links Site to Cost Plus, Amazon and GoodRx

11 ARTICLES

5mo ago

High Court Confirms Thomas Kingston’s Estate Passes to Lady Gabriella After Debts Cut Value to £664,000

10 ARTICLES

6mo ago

Analyses Find Limited Savings as TrumpRx Reaches 54 Drugs

4 ARTICLES

6mo ago

Drug-Cost Anxiety Hits New High in KFF Poll as TrumpRx Sees Limited Reach

9 ARTICLES

7mo ago

Democratic Report Puts TrumpRx Under Fresh Scrutiny as Analyses Question Real-World Savings

11 ARTICLES

7mo ago

Lawmakers Seek Transparency as TrumpRx Faces Questions on Who Saves

9 ARTICLES

7mo ago

TrumpRx Debuts With 43 Discounted Brand Drugs as Analyses Flag Cheaper Generics and Limits

107 ARTICLES

7mo ago

TrumpRx Launches, Offering Discounted Brand‑Name Drugs Through U.S. Portal

13 ARTICLES

7mo ago

White House Launches TrumpRx Portal to Connect Patients With Discounted Drug Offers

5 ARTICLES

7mo ago

Trump Launches TrumpRx.gov With Discounts on More Than 40 Medicines, Including GLP-1 Drugs

7 ARTICLES

9mo ago

White House Adds 9 Pharma Deals, Extending Drug-Price Pacts to 14 Manufacturers

77 ARTICLES

9mo ago

Trump Adds Nine Pharma Giants to Drug Pricing Deals, Reaching 14 Signatories as TrumpRx Nears Launch

6 ARTICLES

10mo ago

Survey Finds Record Anxiety Over U.S. Health Costs as Access Gaps Widen

Prescription Drugs

Administration Ends Temporary Medicare Part D Insurer Subsidy for 2027

CMS Projects U.S. Health Spending Will Reach Nearly $9 Trillion by 2034

White House Adds More Than 600 Generics to TrumpRx and Links Site to Cost Plus, Amazon and GoodRx

DEA Drug Take Back Day Runs Nationwide 10 A.M.–2 P.M.

Trump Seals Regeneron Drug-Pricing Pact, Completing 17-Company Push

RFK Jr. Defends Trump’s Drug-Price Math as Fact-Checkers Call It Wrong

Senate Report Says Drugmakers Raised Prices Despite Trump Deals

California Man Pleads Guilty in $270 Million Medi-Cal Fraud Scheme

High Court Confirms Thomas Kingston’s Estate Passes to Lady Gabriella After Debts Cut Value to £664,000

Analyses Find Limited Savings as TrumpRx Reaches 54 Drugs

Never miss stories about

Prescription Drugs

Drug-Cost Anxiety Hits New High in KFF Poll as TrumpRx Sees Limited Reach

Democratic Report Puts TrumpRx Under Fresh Scrutiny as Analyses Question Real-World Savings

Lawmakers Seek Transparency as TrumpRx Faces Questions on Who Saves

TrumpRx Debuts With 43 Discounted Brand Drugs as Analyses Flag Cheaper Generics and Limits

TrumpRx Launches, Offering Discounted Brand‑Name Drugs Through U.S. Portal

White House Launches TrumpRx Portal to Connect Patients With Discounted Drug Offers

Trump Launches TrumpRx.gov With Discounts on More Than 40 Medicines, Including GLP-1 Drugs

White House Adds 9 Pharma Deals, Extending Drug-Price Pacts to 14 Manufacturers

Trump Adds Nine Pharma Giants to Drug Pricing Deals, Reaching 14 Signatories as TrumpRx Nears Launch

Survey Finds Record Anxiety Over U.S. Health Costs as Access Gaps Widen

Never miss stories about

Prescription Drugs